DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapidacute limb ischaemiaRutherfordembolusthrombosisvascular emergency

Acute limb ischaemia

Essential points for quick revision.

!
Escalate

Acute limb ischaemia is a vascular emergency. New sensory loss or weakness means an immediately threatened limb: contact a vascular specialist at once, give unfractionated heparin unless contraindicated and transfer for urgent revascularisation.

Synopsis

Identify a suddenly threatened limb, grade viability and start time-critical anticoagulation and vascular treatment without avoidable imaging delay.

  • ALI is a sudden fall in limb perfusion, usually within 14 days, that threatens tissue viability.
  • The six Ps—pain, pallor, pulselessness, perishing cold, paraesthesia and paralysis—describe the syndrome, but an incomplete set does not exclude it.
  • Neurological deficit drives urgency: paraesthesia and especially motor weakness indicate a threatened limb.

Key red flags

Rutherford IIa—marginally threatened

Minimal sensory loss, usually toes, with no motor deficit; salvageable if treated promptly.

Investigation priorities

01
Immediate serial neurovascular examination with hand-held DopplerFirst step

Grade limb viability and detect deterioration.

Management branches

first minutesSuspected ALI

Sudden limb pain/coldness, pulse loss, sensory change or weakness.

  1. First: assess ABCs, note exact onset, examine both limbs and document Doppler, sensation and motor power; give analgesia and keep the patient nil by mouth.
  2. Next: contact the on-call vascular specialist immediately and arrange transfer to a centre offering open and endovascular treatment.

Key medicines

Unfractionated heparin5,000 units IV bolus, or 70–100 units/kg IV, followed by an IV infusion adjusted to APTT or ACT response.
MorphineOne licensed injection regimen uses 2.5–10 mg IV, injected slowly over 4–5 minutes; select the lowest effective dose and titrate any further dosing to response in a monitored setting.
Open full textbook Answer 2 questionsCardiology check
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom